Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03348514 |
| Title | Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | CicloMed LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Sarah Cannon Research Institute | Denver | Colorado | 80218 | United States | Details | |
| Florida Cancer Specialists & Research Institute | Sarasota | Florida | 34232 | United States | Details | |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | United States | Details | |
| Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| Tennessee Oncology PLLC | Nashville | Tennessee | 37203 | United States | Details |